Literature DB >> 17828671

Aspartame: a safety evaluation based on current use levels, regulations, and toxicological and epidemiological studies.

B A Magnuson1, G A Burdock, J Doull, R M Kroes, G M Marsh, M W Pariza, P S Spencer, W J Waddell, R Walker, G M Williams.   

Abstract

Aspartame is a methyl ester of a dipeptide used as a synthetic nonnutritive sweetener in over 90 countries worldwide in over 6000 products. The purpose of this investigation was to review the scientific literature on the absorption and metabolism, the current consumption levels worldwide, the toxicology, and recent epidemiological studies on aspartame. Current use levels of aspartame, even by high users in special subgroups, remains well below the U.S. Food and Drug Administration and European Food Safety Authority established acceptable daily intake levels of 50 and 40 mg/kg bw/day, respectively. Consumption of large doses of aspartame in a single bolus dose will have an effect on some biochemical parameters, including plasma amino acid levels and brain neurotransmitter levels. The rise in plasma levels of phenylalanine and aspartic acid following administration of aspartame at doses less than or equal to 50 mg/kg bw do not exceed those observed postprandially. Acute, subacute and chronic toxicity studies with aspartame, and its decomposition products, conducted in mice, rats, hamsters and dogs have consistently found no adverse effect of aspartame with doses up to at least 4000 mg/kg bw/day. Critical review of all carcinogenicity studies conducted on aspartame found no credible evidence that aspartame is carcinogenic. The data from the extensive investigations into the possibility of neurotoxic effects of aspartame, in general, do not support the hypothesis that aspartame in the human diet will affect nervous system function, learning or behavior. Epidemiological studies on aspartame include several case-control studies and one well-conducted prospective epidemiological study with a large cohort, in which the consumption of aspartame was measured. The studies provide no evidence to support an association between aspartame and cancer in any tissue. The weight of existing evidence is that aspartame is safe at current levels of consumption as a nonnutritive sweetener.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17828671     DOI: 10.1080/10408440701516184

Source DB:  PubMed          Journal:  Crit Rev Toxicol        ISSN: 1040-8444            Impact factor:   5.635


  47 in total

1.  Aspartic acid, phenylalanine, and early menarche.

Authors:  Ronald E Kleinman
Journal:  Am J Clin Nutr       Date:  2015-12       Impact factor: 7.045

2.  Quantitative evaluation of boron neutron capture therapy (BNCT) drugs for boron delivery and retention at subcellular-scale resolution in human glioblastoma cells with imaging secondary ion mass spectrometry (SIMS).

Authors:  S Chandra; T Ahmad; R F Barth; G W Kabalka
Journal:  J Microsc       Date:  2014-03-31       Impact factor: 1.758

3.  A theoretical and experimental study of calcium, iron, zinc, cadmium, and sodium ions absorption by aspartame.

Authors:  Karim Mahnam; Fatame Raisi
Journal:  J Biol Phys       Date:  2017-02-01       Impact factor: 1.365

4.  An electronic tongue: evaluation of the masking efficacy of sweetening and/or flavoring agents on the bitter taste of epinephrine.

Authors:  Ousama Rachid; F Estelle R Simons; Mutasem Rawas-Qalaji; Keith J Simons
Journal:  AAPS PharmSciTech       Date:  2010-03-30       Impact factor: 3.246

5.  Aspartame and Soft Drink-Mediated Neurotoxicity in Rats: Implication of Oxidative Stress, Apoptotic Signaling Pathways, Electrolytes and Hormonal Levels.

Authors:  Mohamed A Lebda; Kadry M Sadek; Yasser S El-Sayed
Journal:  Metab Brain Dis       Date:  2017-06-28       Impact factor: 3.584

6.  Behavioral effects of Splenda, Equal and sucrose: Clues from planarians on sweeteners.

Authors:  Kevin Ouyang; Sunil Nayak; Young Lee; Erin Kim; Michael Wu; Christopher S Tallarida; Scott M Rawls
Journal:  Neurosci Lett       Date:  2016-11-11       Impact factor: 3.046

7.  Investigating nutrition and lifestyle factors as determinants of abdominal obesity: an environment-wide study.

Authors:  W Wulaningsih; M Van Hemelrijck; K K Tsilidis; I Tzoulaki; C Patel; S Rohrmann
Journal:  Int J Obes (Lond)       Date:  2016-11-14       Impact factor: 5.095

8.  Impact of substituting added sugar in carbonated soft drinks by intense sweeteners in young adults in the Netherlands: example of a benefit-risk approach.

Authors:  Marieke A Hendriksen; Mariken J Tijhuis; Heidi P Fransen; Hans Verhagen; Jeljer Hoekstra
Journal:  Eur J Nutr       Date:  2010-04-29       Impact factor: 5.614

Review 9.  Nonnutritive sweetener consumption in humans: effects on appetite and food intake and their putative mechanisms.

Authors:  Richard D Mattes; Barry M Popkin
Journal:  Am J Clin Nutr       Date:  2008-12-03       Impact factor: 7.045

Review 10.  Artificial sweeteners - a review.

Authors:  Sanchari Chattopadhyay; Utpal Raychaudhuri; Runu Chakraborty
Journal:  J Food Sci Technol       Date:  2011-10-21       Impact factor: 2.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.